Company intelligence / Profile preview

Howard

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Howard is a stealth-mode biotechnology company focused on developing novel therapeutic approaches. While specific details regarding its pipeline and technology platform remain proprietary, the company is backed by prominent venture capital firms including ARCH Venture Partners and F-Prime Capital. Howard is part of a wave of early-stage startups aiming to address significant unmet medical needs through innovative drug discovery. The company is currently building its leadership team and advancing its foundational research in the life sciences sector.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Howard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Howard.

Explore the full profile